Comment
Author: Admin | 2025-04-28
*TAP TO EXPAND* The Drug Recall Report is for prescription drugs that are have recently been issued recalls by the U.S. Food and Drug Administration (FDA). Here’s what you should do if your prescription medications are recalled: Do not continue to use any recalled prescription medicineContact your provider or pharmacist if you have experienced any reactions.Check your prescription label for the drug lot number and the expiration date to see if any of your medication is affected by the recall.If you have the medication, contact the pharmacy that you received it from. Any adverse actions or events from the use of prescription drugs should be reported to FDA here or calling 1-800-FDA-0178.Stay up to date with current recall notices by visiting the FDA website.CLONAZEPAM 0.125 MG ODT TABLETOn 1/15/2025, ENDO USA, INC recalled CLONAZEPAM 0.125 MG ODT TABLET due to Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength. The U.S. Food and Drug Administration (FDA) has issued a Class I Recall of the affected medications.More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.The detailed information of the recalled product is listed below:Recalled Drug: CLONAZEPAM 0.125 MG ODT TABLETNDC Number: 49884030602Lot Number(s): 550174101Expiration Date(s): 1/31/2024What you should do:Do not continue to use CLONAZEPAM 0.125 MG ODT TABLET if it has been recalledCheck your prescription label to see if you have any CLONAZEPAM in the affected lot numbers and expiration dates.If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.CLONAZEPAM 0.25 MG ODT TABLETOn 1/15/2025 ENDO USA, INC recalled CLONAZEPAM 0.25 MG ODT TABLET due to Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength. The U.S. Food and Drug Administration (FDA) has issued a Class I Recall of the affected medications.More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.The detailed information of the recalled product is listed below:Recalled Drug: CLONAZEPAM 0.25 MG ODT TABLETNDC Number: 49884030702Lot Number(s): 550142801, 550142901, 550143001, 550143101, 550143201, 550143301, 550143401, 550147201 AND 550147401Expiration Date(s): 08/31/2026What you should do:Do not continue to use CLONAZEPAM 0.25 MG ODT TABLET if it has been recalledCheck your prescription label to see if you have any CLONAZEPAM in the affected lot numbers and expiration dates.If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting www.fda.gov/medwatch/report.htm or calling 1-800-FDA-0178.CLONAZEPAM 1 MG ODT TABLETOn 1/15/2025, ENDO USA, INC recalled CLONAZEPAM 1 MG ODT TABLET due to Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength. The U.S. Food and Drug Administration (FDA) has issued a Class I Recall of the affected medications.More information about the recall is at: https://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.The detailed information of the recalled product is
Add Comment